Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$1.31 - $1.79 $5,502 - $7,518
-4,200 Reduced 27.3%
11,183 $17,000
Q1 2023

May 15, 2023

SELL
$1.48 - $2.19 $90,971 - $134,612
-61,467 Reduced 79.98%
15,383 $23,000
Q4 2022

Feb 14, 2023

BUY
$1.25 - $1.94 $37,406 - $58,054
29,925 Added 63.77%
76,850 $129,000
Q3 2022

Nov 14, 2022

SELL
$1.19 - $2.06 $148,359 - $256,824
-124,672 Reduced 72.65%
46,925 $58,000
Q2 2022

Aug 15, 2022

BUY
$1.59 - $2.7 $41,192 - $69,948
25,907 Added 17.78%
171,597 $287,000
Q1 2022

May 16, 2022

SELL
$2.02 - $3.92 $84,276 - $163,546
-41,721 Reduced 22.26%
145,690 $358,000
Q4 2021

Feb 14, 2022

BUY
$3.74 - $6.7 $349,424 - $625,974
93,429 Added 99.41%
187,411 $701,000
Q3 2021

Nov 15, 2021

BUY
$6.05 - $10.41 $8,839 - $15,209
1,461 Added 1.58%
93,982 $589,000
Q2 2021

Aug 16, 2021

SELL
$6.66 - $10.92 $1.3 Million - $2.13 Million
-195,234 Reduced 67.85%
92,521 $912,000
Q1 2021

May 17, 2021

BUY
$4.59 - $18.74 $1.02 Million - $4.16 Million
222,144 Added 338.58%
287,755 $2.69 Million
Q4 2020

Feb 16, 2021

SELL
$3.93 - $5.5 $47,533 - $66,522
-12,095 Reduced 15.57%
65,611 $315,000
Q3 2020

Nov 16, 2020

SELL
$4.01 - $5.56 $269,119 - $373,142
-67,112 Reduced 46.34%
77,706 $312,000
Q2 2020

Aug 14, 2020

BUY
$3.0 - $5.52 $434,454 - $799,395
144,818 New
144,818 $665,000
Q1 2018

May 15, 2018

SELL
$4.05 - $6.46 $99,905 - $159,355
-24,668 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$3.88 - $6.96 $95,711 - $171,689
24,668
24,668 $145,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $510M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.